NCT06220448 Blunt ADrenal Gland injUrY (BAD GUY) Project
| NCT ID | NCT06220448 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Niguarda Hospital |
| Condition | Trauma |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2024-01-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Type: retrospective observational multicenter trial. Population of interest: adult patients suffering from thoraco-abdominal trauma undergoing both non-operative and operative management. Hypothesis: Adrenal gland injury is a rare finding after blunt thoracoabdominal trauma. Short-term outcomes of blunt adrenal gland injury (BAGI) described in literature are contradictory. Reports on the outcomes related to this injury are variable and consider heterogeneous populations of trauma patients Aim: This study aims to explore the burden related to BAGI in an homogeneous population of patients sustaining blunt thoraco-abdominal trauma treated in different institution
Eligibility Criteria
Inclusion criteria: * Age \> 16 years old * All patients with blunt thoraco-abdominal trauma Exclusion criteria: * TBI with AIS \> 3 * Isolated TBI and Spinal cord injury * Patients died in emergency department
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06220448 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 99 Years, studying Trauma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06220448 currently recruiting?
Yes, NCT06220448 is actively recruiting participants. Contact the research team at stefanopiero.cioffi@ospedaleniguarda.it for enrollment information.
Where is the NCT06220448 trial being conducted?
This trial is being conducted at Miano, Italy.
Who is sponsoring the NCT06220448 clinical trial?
NCT06220448 is sponsored by Niguarda Hospital. The trial plans to enroll 5,000 participants.